WF11899A, B and C, novel antifungal lipopeptides. II. Biological properties

The Journal of Antibiotics

Volumn 47, Issue 10, 1994, Pages 1092-1097

  Iwamoto, Toshiro ^a   Fujie, Akihiko ^a   Nitta, Kumiko ^a   Hashimoto, Seiji ^a   Okuhara, Masakuni ^a   Kohsaka, Masanobu ^a  

^a ASTELLAS PHARMA INC   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1,3 BETA GLUCAN SYNTHASE; ACULEACIN A; AMPHOTERICIN B; ANTIFUNGAL AGENT; CILOFUNGIN; ECHINOCANDIN B DERIVATIVE; FLUCONAZOLE; LIPOPEPTIDE; UNCLASSIFIED DRUG; WF 11899 A; WF 11899 B; WF 11899 C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIFUNGAL ACTIVITY; ARTICLE; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDA ALBICANS; CONTROLLED STUDY; DILUTION; DRUG ACTIVITY; DRUG POTENCY; DRUG SOLUBILITY; ENZYME INHIBITION; ERYTHROCYTE; FEMALE; FUNGUS GROWTH; HEMOLYSIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMAL; ANTIFUNGAL AGENTS; ASPERGILLUS FUMIGATUS; ASPERGILLUS NIGER; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; COMPARATIVE STUDY; GLUCOSYLTRANSFERASES; HEMOLYSIS; MICE; MICE, INBRED ICR; PEPTIDES, CYCLIC;

EID: 0028148187     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.7164/antibiotics.47.1092     Document Type: Article

References (12)

1. Iwamoto, T.; A. Fujie, K. Sakamoto, Y. Tsurumi, N. Shigematsu, M. Yamashita, S. Hashimoto, M. Okuhara & M. Kohsaka: WF11899A, B, and C, novel antifungal lipopeptides. I. Taxonomy, fermentation, isolation and physico-chemical properties. J. Antibiotics 47: 1084~1091, 1994.
2. Mizoguchi, J.; T. Saito, K. Mizuno & K. Hayano: On the mode of action of a new antifungal antibiotic, aculeacin A: Inhibition of cell wall synthesis in Saccharomyces cerevisiae. J. Antibiotics 30: 308~313, 1977.
3. Yamaguchi, H.; T. Hiratani, K. Iwata & Y. Yamamoto: Studies on the mechanism of antifungal action of aculeacin A. J. Antibiotics 35: 210~219, 1982.
4. Sawistowska-Schröder, E. T.; D. Kerridge & H. Perry: Echinocandin inhibition of l,3-β-o-glucan synthase from Candida albicans. FEBS Lett. 173: 134-138, 1984.
5. Debono, M.; B. J. Abbott, J. R. Turner, L. C. Howard, R. S. Gordee, A. S. Hunt, M. Barnhart, R. M. Molloy, K. E. Willard, D. Fukuda, T. F. Butler & D. J. Zeckner: Synthesis and evaluation of LY121019, a member of a series of semisynthetic analogues of the antifungal lipopeptide echinocandin B. Ann. N. Y. Acad. Sci. 544: 152~167, 1988.
6. Gordee, R. S.; D. J. Zeckner, L. F. Ellis, A. L. Thakkar & L. C. Howard: In vitro and in vivo anti-Candida activity and toxicology of LY121019. J. Antibiotics 37: 1054~1065, 1984.
7. Debono, M.; B. J. Abbott, D. S. Fukuda, M. Barnhart, K. E. Willard, R. M. Molloy, K. H. Michel, J. R. Turner, T. F. Butler & A. H. Hunt: Synthesis of new analogs of echinocandin B by enzymatic deacylation and chemical reacylation of the echinocandin B peptide: Synthesis of the antifungal agent cilofungin (LY121019). J. Antibiotics 42: 389ö397, 1989.
8. Fromtling, R. A. & G. K. Abruzzo: L-671,329, a new antifungal agent. III. In vitro activity, toxicity and efficacy in comparison to aculeacin. J. Antibiotics 42: 174~178, 1989.
9. Denning, D. W. & D. A. Stevens: Efficacy of cilofungin alone and in combination with amphotericin B in a murine model of disseminated aspergillosis. Antimicrob. Agents Chemother. 35: 1329~1333, 1991.
10. Beaulieu, D.; J. Tang, D. J. Zeckner & T. R. Parr Jr.: Correlation of cilofungin in vivo efficacy with its activity against Aspergillus fumigatus (1,3)-β-D-glucan synthase. FEMS Microb. Lett. 108: 133~138, 1993.
11. Boeck, L. D.; D. S. Fukuda, B. J. Abbott & M. Debono: Deacylation of echinocandin B by Actinoplanes utahensis. J. Antibiotics 42: 382-388, 1989.
12. Schmatz, D. M.; G. Abruzzo, M. A. Powles, D. C. Mcfadden, J. M. Balkovec, R. M. Black, K. Nollstadt & K. Bartizal: Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species. J. Antibiotics 45: 1886~1891, 1992.